COVID-19 public health information from the US CDC |
COVID-19 research information from the US NIH |
COVID-19 resources for global health researchers
NIH Global Health Funding News - Week of November 14, 2016
On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding
opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates
are typically distributed once a week.
NIH funding opportunities focusing on global health and foreign collaboration.
NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.
- Research funding from the National Cancer Institute:
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21) (RFA-CA-17-010)
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33) (RFA-CA-17-011)
Innovative Technologies for Cancer-Relevant Biospecimen Science (R21) (RFA-CA-17-012)
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33) (RFA-CA-17-013)
Application Receipt Date(s): February 28, 2017; May 26, 2017; September 26, 2017
Other opportunities for NIH-supported researchers working in global health:
Information related to opportunities focusing on global health and foreign collaboration from other organizations.
- GSK's Africa NCD Open Lab is for outstanding African scientists in the early stages of their research and academic careers based in research institutions or universities in Cameroon, Côte D’Ivoire, Ethiopia, Ghana, The Gambia, Kenya, Malawi, Nigeria, Uganda, Senegal and Tanzania.
Due January 12, 2017
NIH funding news that may be relevant to global health researchers.
- Request for Information (RFI): Strategic Plan for the National Library of Medicine, National Institutes of Health (NOT-LM-17-002)
- Request for Information (RFI): Effects of Extrinsic Environmental Factors on Animal Research: Rigor and Reproducibility (NOT-OD-17-011)
- Notice of Extension of the Response Date for NOT-CA-16-067 RFI Epidemiology Research on Novel Infectious Agents and Cancer Occurrence and Outcomes (NOT-CA-17-001)
- Notice of Extension of the Response Date for NOT-HL-16-440 RFI for Bethesda+40: Forty Years after the Bethesda Conference on Declining Mortality from Coronary Heart Disease (NOT-HL-16-463)
Note: The NHLBI proposes to bring together leading experts in a broad range of fields to consider from a global perspective where we are in terms of understanding the direction, magnitude, differences, and drivers of trends in cardiovascular disease worldwide.
- Notice of Participation of NIDCR (NOT-DE-16-006) and NIMHD (NOT-MD-16-011) in PAR-15-349 Health Disparities and Alzheimer's Disease (R01)
- Notice of NHLBI Participation in PAS-16-033 Stimulating Hematology Investigation: New Endeavors (SHINE) (R01) (NOT-HL-16-460)